Enzymatic Vitreolysis for Vitreomacular Traction in Diabetic Retinopathy

Clicks: 302
ID: 268076
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Vitreomacular traction (VMT) is one of many possible factors involved in the etiology of diabetic macular edema (DME). Pharmacologic vitreoretinal separation is a potential alternative to vitrectomy for VMT in diabetic retinopathy. Small case series have been published on the use of enzymatic vitreo …
Reference Key
s2017developmentsenzymatic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rizzo S;Bacherini D;;
Journal Developments in ophthalmology
Year 2017
DOI
DOI not found
URL
https://www.pubmed.gov/28427074/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine Tomography Optical Coherence diabetic retinopathy / drug therapy* intravitreal injections visual acuity* stanislao rizzo daniela bacherini pmid:28427074 doi:10.1159/000460275 diabetic retinopathy / complications diabetic retinopathy / diagnosis fibrinolysin / administration & dosage* vitreous body / drug effects* vitreous detachment / diagnosis vitreous detachment / drug therapy* vitreous detachment / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.